Introduction
Biogenesis and function of exosome
Isolation and detection of exosomes
Origins, biogenesis and functions of circRNA
Origins of circRNA
Biogenesis of circRNA
Functions of circRNA
miRNA sponge
Regulation of transcription and alternative splicing
Translation
Interactions with RBPs
Origin and mechanism of exosomal circRNAs
Exosomal circRNAs in cancers
circRNA | Cancer type | Expression | Biological function | Mechanism | Citation |
---|---|---|---|---|---|
circ-0051443 | HCC | Downregulated | Promote cell apoptosis and arrest the cell cycle | circ-0051443/miR-331-3p/BAK1 | [80] |
circ-DB | HCC | Upregulated | Promote growth and reduce DNA damage | circ-DB/miR-34a /USP7 | [81] |
Cdr1as | HCC | Upregulated | Promote proliferation and migration | Cdr1as/miR-1270/AFP | [82] |
circNRIP1 | GC | Upregulated | Promote tumour metastasis | circNRIP1/miR-149-5p/AKT1 | [83] |
ciRS-133 | GC | Upregulated | Promote cancer-associated cachexia | ciRS-133/miR-133/PRDM16 | [5] |
Circ-RanGAP1 | GC | Upregulated | Promote invasion and metastasis | circ-RanGAP1/miR-877-3p/VEGFA | [24] |
circLONP2 | CRC | Upregulated | Promote invasion and metastasis | circLONP2 /miR-17/DGCR8 | [84] |
ciRS-122 | CRC | Upregulated | Promote glycolysis and drug resistance | ciRS-122/miR-122/PKM2 | [85] |
circ-ABCC1 | CRC | Upregulated | Promote cell stemness, sphere formation and metastasis | circ-ABCC1/Wnt /β-catenin | [86] |
circIFT80 | CRC | Upregulated | Promote the proliferation, migration and invasion | circIFT80 /miR-1236-3p /HOXB7 | [87] |
circFMN2 | CRC | Upregulated | Promote proliferation and migration | circFMN2/miR-1182 /hTERT | [88] |
circ-PDE8A | PDAC | Upregulated | Promote proliferation and invasion | Circ-PDE8A /miR-338/MACC1 | [25] |
Circ-IARS | PDAC | Upregulated | Promoting tumor invasion and metastasis | circ-IARS/miR-122/RhoA | [89] |
CircPUM1 | ovarian cancer | Upregulated | Promote proliferation, migration and invasion | CircPUM1 /miR-615-5p/miR-6753-5p/NF-Κb/MMP2 | [90] |
CircWHSC1 | ovarian cancer | Upregulated | Promote proliferation and metastasis | CircWHSC1/miR-145/miR-1182 | [91] |
Cdr1as | ovarian cancer | Downregulated | Inhibit proliferation and promot cisplatin-induced cell apoptosis | Cdr1as/miR-1270/SCAI | [92] |
CircSATB2 | NSCLC | Upregulated | Promotes proliferation, migration and invasion | circSATB2/miR-326/FSCN1 | [93] |
Circ_0044516 | prostate cancer | Upregulated | Promote growth and metastasis | Circ_0044516/miR‐29a‐3p | [94] |
CircPRMT5 | UCB | Upregulated | Promote growth and metastasis | circPRMT5/miR-30c/SNAIL1/E-cadherin | [95] |
circRASSF2 | LSCC | Upregulated | Promote proliferation | circRASSF2/miR-302b-3p/IGF-1R | [96] |
mc-COX2 | CLL | Upregulated | Promote proliferation and inhibit apoptosis | – | [97] |
CircRASSF2 | PTC | Upregulated | Promote proliferation and inhibit apoptosis | CircRASSF2/miR-1178/TLR4 | [98] |
Hepatocellular carcinoma (HCC)
Gastric cancer (GC)
Colorectal cancer (CRC)
Pancreatic cancer
Ovarian cancer
Breast cancer
Lung cancer
Urinary system cancer
Other tumors
circRNA | Diseases | Expression | Biological function | Mechanism | Citation |
---|---|---|---|---|---|
CircHIPK3 | Cardiomyocytes | Upregulated | Decrease in oxidative stress-induced CMVECs dysfunction | CircHIPK3/miR-29a/IGF-1 | [107] |
cZFP609 | Ischemic diseases | Upregulated | Inhibit endothelial angiogenic activity induced by hypoxia | cZFP609 /HIF1α/VEGFA | [108] |
circHIPK3 | Ischemic injury of the skeletal muscle | Downregulated | Improve blood perfusion, inhibit ischemia induced pyroptosis | circHIPK3/miR-421 /FOXO3a | [32] |
circ-Rtn4 | Osteoporosis | Upregulated | Increase cell activity and inhibit apoptosis | circ-Rtn4/miR-146a/TNF-α | [109] |
circRNA-0077930 | Vascular smooth muscle aging | Upregulated | Promote cellular senescence of VSMCs | circRNA-0077930/miR-622/Kras | [110] |
Exosomal circRNAs in other disease
CircRNA | Disease type | Specimen source | Specimen type | Expression | AUC | Citation |
---|---|---|---|---|---|---|
hsacirc_020135 | PTC | PTC/benign thyroid goiter | Serum | Downregulated | – | [105] |
hsa circ 0002577 | Endometrial cancer | Endometrial cancer/healthy | Serum | Upregulated | – | [106] |
hsa_circ_0065149 | GC | GC/healthy/gastritis | Plasma | Downregulated | 0.769 | [100] |
three-circRNA signature | HCC | HCC/healthy | Serum | Upregulated | 0.89 | [99] |
hsa-circRNA-0088088 | Breast cancer | Breast cancer/healthy | Serum | Upregulated | – | [102] |
hsa-circRNA-00005795 | Breast cancer | Breast cancer/healthy | Serum | Downregulated | – | [102] |
CircRNA-002178 | LUAD | LUAD/healthy | Serum | Upregulated | 0.9956 | [104] |
hsa_circRNA_0056616 | LUAD | With lymph node metastasis/without | Plasma | Upregulated | 0.812 | [103] |
Circ-0051443 | HCC | HCC/healthy | Plasma | Downregulated | 0.8089 | [80] |
circ-0004771 | CRC | CRC/healthy | Serum | Upregulated | 0.88 | [114] |
hsa_circ_0087862 | Immune-mediated demyelinating | Immune-mediated demyelinating/healthy | Cerebrospinal fluid | Upregulated | 1 | [115] |
circ-KIAA1244 | GC | GC/healthy | Plasma | Downregulated | 0.7481 | [116] |